ACTRN12624000874516
Not yet recruiting
未知
PRO-Health – A remotely-delivered prostate cancer specific personalised healthy eating and exercise program to manage side effects from androgen deprivation therapy: A feasibility, acceptability and preliminary efficacy pilot trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Deakin University
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 18\+ years
- •2\. A diagnosis of prostate cancer and treated with Androgen Deprivation Therapy for \>3 months
- •3\. Body mass index \<40 kg/m2
- •4\. Not currently meeting the dietary and exercise guidelines for cancer survivors or under the care of a nutrition or exercise health professional
- •5\. Not taking any supplements other than a single multivitamin; unless stated for medical purpose (i.e., vitamin D supplement for low bone mineral density)
- •6\. Free of any musculoskeletal, neurological, respiratory, metabolic or cardiovascular conditions that may prevent safe completion of the exercise demands of the study.
- •7\. Access to a smart device with stable internet and video capabilities
- •8\. English is your primary language
Exclusion Criteria
- •1\. Body mass index \<24\.9 kg/m2 (healthy weight or underweight), weight \>200 kg
- •2\. Bone metastases
- •3\. Any electronic medical implant such as a pacemaker
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Transmurale zorg Prostaatkanker, van diagnose tot en met nazorgProstate cancer, transmural care, decision aid, SDM, Follow-up care, Substitution, Family doctors or General practitioners, Prostaatkanker, Keuzehulp, Samenwerking tussen eerste lijn en tweede lijn.NL-OMON22953Initiator: Catharina Wilhelmina Hospital (CWZ)NijmegenPrimary Sponsor/Performer: Radboud University Nijmegen Medical centerOther performers: CWZ in Nijmegen, Maashospital Pantein in Boxmeer200
Recruiting
Not Applicable
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyProstate cancerCancer - ProstateACTRN12612000523808Flack Trustees6
Recruiting
Phase 2
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100
Recruiting
Not Applicable
Prostate cancer Research International: Active Surveillance (PRIAS) MRI studyNL-OMON50734Erasmus MC, Universitair Medisch Centrum Rotterdam30
Recruiting
Not Applicable
The *Utrecht Prostate Cohort for cancer treatment intervention studies and long term evaluation (UPC)* studyProstate cancer1003859710018188NL-OMON50026niversitair Medisch Centrum Utrecht5,000